Budiair

Chiesi Farmaceutici is an international research-focused pharmaceutical group based in Parma, Italy, with over 85 years of experience in the healthcare sector. The company is a global leader in the respiratory health market, known for its innovative drug delivery systems and treatments for asthma and chronic obstructive pulmonary disease (COPD), including the Budiair brand of budesonide. Beyond respiratory care, Chiesi has a significant presence in neonatology, rare diseases, and specialty care. As a certified B Corp, the company integrates social and environmental sustainability into its business model while maintaining a robust pipeline of therapeutic solutions across its core areas of focus.